Kyverna Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Kyverna Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2023 to Q2 2024.
  • Kyverna Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $215M.
Marketable Securities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $215M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $146M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $22.9M Dec 31, 2023 10-Q 2024-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.